Hot Pursuit     13-Sep-23
Zydus Life rises after receiving EIR report for Ahmedabad-based facility from US FDA
Zydus Lifesciences added 1.90% to Rs 639.60 after the company announced the receipt of EIR report from the USFDA for the inspection conducted at the injectables manufacturing facility at Zydus Biotech Park, Changodar, Ahmedabad.

The inspection, carried out between 5th and 13th of June 2023, was a cGMP Inspection and had ended with NIL observations.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company had reported 109.7% surge in net profit to Rs 1,086.9 crore in Q1 FY24 as compared with Rs 518.3 crore posted in Q1 FY23. Revenue from operations jumped 29.6% to Rs 5,139.6 crore during the quarter as compared with Rs 3,964.4 crore recorded in same quarter last year.

Previous News
  Stock Alert: Zydus Lifesciences, Galaxy Surfactants, IOL Chemicals & Pharmaceuticals, R System Intl
 ( Market Commentary - Stock Alert 06-Mar-25   08:32 )
  Zynext Ventures invests in Illexcor Therapeutics
 ( Corporate News - 13-Mar-25   12:21 )
  Zydus Lifesciences Ltd spurts 2.11%, up for third straight session
 ( Hot Pursuit - 06-Mar-25   13:05 )
  Zydus receives USFDA approval for Dasatinib Tablets
 ( Corporate News - 05-Mar-25   19:06 )
  Zydus Life gets USFDA nod for Lidocaine and Prilocaine Cream USP
 ( Hot Pursuit - 19-Dec-24   12:49 )
  Volumes spurt at Zydus Lifesciences Ltd counter
 ( Hot Pursuit - 07-Jan-25   11:00 )
  Zydus Life gains as arm gets USFDA nod for priority review of CUTX-101
 ( Hot Pursuit - 07-Jan-25   10:02 )
  Zydus Lifesciences rises after receiving US FDA approval for leukemia treatment drug Dasatinib
 ( Hot Pursuit - 06-Mar-25   09:44 )
  Zydus Lifesciences Ltd spurts 1.03%, rises for third straight session
 ( Hot Pursuit - 03-Dec-24   13:06 )
  Zydus Lifesciences receives USFDA approval for Lidocaine and Prilocaine Cream
 ( Corporate News - 19-Dec-24   14:58 )
  Zydus Lifesciences Ltd spurts 1.16%, rises for third straight session
 ( Hot Pursuit - 26-Feb-24   13:05 )
Other Stories
  HDFC Bank Q4 PAT rises 7% YoY to Rs 17,616 cr; NII rises 10%
  19-Apr-25   18:04
  Yes Bank Q4 PAT climbs 63% YoY to Rs 738 cr
  19-Apr-25   16:20
  Mastek Q4 PAT slides 14% QoQ to Rs 81 cr; recommends final dividend of Rs 16/sh
  19-Apr-25   14:31
  Tata Elxsi posts PAT of Rs 172 crore in Q4; EBITDA margin at 20.5%
  19-Apr-25   12:47
  Mahindra EPC records more than fourfold rise in Q4 PAT
  19-Apr-25   11:04
  Just Dial Q4 PAT climbs 36% YoY to Rs 158 cr
  19-Apr-25   10:02
  Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr
  19-Apr-25   08:57
  HDFC Life Q4 PAT climbs 16% YoY to Rs 476 cr
  17-Apr-25   17:32
  Infosys Q4 PAT rises 3% QoQ to Rs 7,038 cr; declares dividend of Rs 22/sh
  17-Apr-25   17:25
  HDFC AMC rises after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh
  17-Apr-25   17:11
Back Top